Autism Newsroom: Medical News Today

Texas Raises Organ Donor Registry; D.C. Not Ready For Medical Marijuana Sales; L.A. Health Department Facing Major Service Cuts Thu, 29 Jul 2010 04:00:00 PDT

The Houston Chronicle: "Though Texas has the nation's lowest percentage of registered organ and tissue donors, several recent initiatives have more than doubled the state's donor rolls this year. The number enrolled in the Glenda Dawson Donate Life Texas Registry has ballooned since Jan...

New York State Approves Quest Diagnostics' Fragile X Syndrome Test Thu, 29 Jul 2010 02:00:00 PDT

An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism...

Curemark Opens Autism Trials At New Jersey Site Thu, 29 Jul 2010 02:00:00 PDT

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participating in the company's Phase III clinical trials for CM-AT, Curemark's autism treatment. Saint Peter's is affiliated with the Drexel University College of Medicine in Philadelphia...

Autism Charity Raises The Bar For Legal Campaigning, UK Thu, 29 Jul 2010 01:00:00 PDT

The National Autistic Society (NAS) has ramped up its legal campaigning with the launch of a new Autism Legal Network and a call for cases with the potential to change the law for the half a million people with autism in the UK. Mark Lever, chief executive of the NAS said; "The NAS is evolving. Last year we successfully secured the landmark Autism Act...

Seaside Therapeutics Reports Data From Randomized, Placebo-Controlled Phase 2 Study In Fragile X Syndrome Wed, 28 Jul 2010 01:00:00 PDT

Seaside Therapeutics, Inc. announced data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population...

Asuragen And Collaborators Report Results Using PCR-Only Technologies For The Comprehensive Molecular Assessment Of The Fragile X Gene Tue, 27 Jul 2010 00:00:00 PDT

Asuragen, Inc. announced the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods...

XenoPort Announces Presentation Of Preclinical Data For Acamprosate Prodrug At Fragile X Syndrome Conference Tue, 27 Jul 2010 00:00:00 PDT

XenoPort, Inc. (Nasdaq:XNPT) announced that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan...

Leading Researchers To Share New Treatments At Fragile X International Conference Fri, 23 Jul 2010 03:00:00 PDT

Accelerated research findings leading to potentially significant new treatments for fragile X syndrome (FXS) will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25...

New Survey By Enzymedica Links Autism & Digestion, Suggests Successful Strategies Fri, 23 Jul 2010 00:00:00 PDT

Autism is the fastest growing developmental disorder in the world. With 1 child in 91 facing the disorder, the diagnosis is more common than pediatric cancer, diabetes, and AIDS combined...

A National Autistic Society Response To The Commission On The Funding Of Care And Support, UK Wed, 21 Jul 2010 10:00:00 PDT

The National Autistic Society (NAS) has welcomed the establishment of the Commission on the Funding of Care and Support today, but urged that it must consider how to fund support for those with lifelong conditions, such as autism, who are less able to save and pay for their social care...